VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD CURE.L
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
CURE.L Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is classified as not halal.
NOT HALAL
Is VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD Halal?
Shariah Compliance Analysis of CURE.L ETF
GB Equity Theme No. As of September 2026, VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE.L) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD does not pass Musaffa's business and financial screening criteria.
CURE.L was created on 2022-09-02 by VanEck. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 18.13m in AUM and 50 holdings. The Funds investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE.L) Chart
Key Statistics of VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE.L)
Today's Open
-AUM
-Avg. Volume
-Expense Ratio
-P/E Ratio
-P/B Ratio
-FAQ's for VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE.L)
- As of September 2026, VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD CURE.L is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD using these criteria to determine its compliance status.
- The Shariah compliance status of VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
- Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
- You can check the latest Shariah compliance status of VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.